CAR-PRISM trial reports promising results in high-risk smoldering multiple myeloma
Summary
Results of the single-center, phase 2 CAR-PRISM (PRecision Intervention Smoldering Myeloma) clinical trial, the first to investigate Chimeric Antigen Receptor (...
Description
Results of the single-center, phase 2 CAR-PRISM (PRecision Intervention Smoldering Myeloma) clinical trial, the first to investigate Chimeric Antigen Receptor (...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source